Clip Health joined more than 500 distributors at NDC Exhibition 2022, April 11-12, at the Gaylord Opryland Resort & Convention Center in Nashville, where the company showcased its smartphone-based COVID-19 antigen test, as well as a preview of the new Clip Core Analyzer, which will launch in June of 2021. Clip Health’s COVID-19 antigen test is the most accurate on the market, with 100% NPA/Specificity and 96.9% PPA/Sensitivity. As we move into a new phase of COVID-19, test results will need to be accurate and provide usable data to understand the result. Clip Health was pleased to lead conversations with strategic partners about the future of diagnostic testing, and effective use of results data.
For decades, the need for accurate and speedy diagnostics has remained a constant driver of the clinical testing industry. However, the ability to easily collect and share that data, once collected, is what is moving the needle – and fueling new models of POC testing. Beyond COVID, accurate and immediately usable diagnostic tools will address community and institutional public health needs surrounding highly transmissible illness and disease.
NDC believes that the relationships formed between their network of member distributors and manufacturer partners are vital in maintaining a competitive edge in the healthcare distribution industry. Clip Health was proud to share its own proprietary technology and also benefited from hearing first hand about the problems and challenges organizations face around usability of testing data. From clinical environments and healthcare IT (HCIT) organizations, to hospitality and higher education, NDC 2022 provided a great experience for industries tasked with making information meaningful.
Clip Health welcomes engaging, like-minded organizations who are keen to protect and improve the health and wellness of communities through the most accurate diagnostic, data capture, and sharing platform. We look forward to seeing you at a conference in 2022!
 Source: AdVeritasDx Test Database